2 completed. 2 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
| Phase 3 | 1 | Completed 1 |
Follow Colestipol: new trials by email Literature Review of Colestipol trials Research Report on Colestipol
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| An Open-Label Study to Characterize the Incidence and Severity of Diarrhea in Patients With Early-Stage HER2+ Breast Cancer Treated With Neratinib and Loperamide Neratinib, Loperamide, Colestipol - Early Stage HER2+ Breast Cancer | Phase 2 | Completed | Puma Biotechnology, Inc. | 563 | 2015-02-01 | 2022-05-06 |
| Sorbent Therapy of the Cutaneous Porphyrias Colestipol - Erythropoietic Protoporphyria | Phase 2 / Phase 3 | Completed | Brigham and Women's Hospital | 4 | 2011-05-01 | 2017-04-25 |
Breast Neoplasms (1) · Protoporphyria, Erythropoietic (1)
Brigham and Women's Hospital (1) · Puma Biotechnology, Inc. (1)
United States (2) · Australia (1) · Austria (1) · Canada (1) · France (1) · Germany (1) · Spain (1)
2015 (1)